Appointment New Patient Appointment or 214-645-8525

Our team of experts offers the most advanced treatments and technologies to treat patients diagnosed with lymphoma. As the only National Cancer Institute-designated comprehensive cancer center in North Texas, we deliver the best cancer care available today and push to discover new treatments. NCI designation means we offer patients the ability to participate in the broadest possible range of clinical trials, with access to potential therapies not available at other facilities.

Meet Our Team

Kiran Kumar, M.D., M.B.A., Chief of Lymphoma Radiation Oncology Service

Kiran Kumar, M.D., M.B.A., Chief of Lymphoma Radiation Oncology Service

Margaret Kozak, M.D.

Margaret Kozak, M.D.

Meet Dr. Kozak

Educational Materials 

Lymphoma Clinical Trials

As one of the top academic medical centers in the country and the only NCI-designated cancer center in North Texas, we lead and participate in a number of clinical trials aimed at improving the outcomes of patients with cancer. Our Department enrolls approximately 200 new patients in clinical trials each year. 

Clinical trials are critical in developing new therapies for cancer and can mean having access to new medication, groundbreaking research, and additional clinical care. Our clinical trials team is comprised of radiation oncologists, radiation biologists, clinical research coordinators, quality assurance coordinators, and clinical data specialists.


STU 2020.1106 (Repriming CAR-T) A Phase I/II Trial of ‘Re-Priming’ Stereotactic Ablative Radiotherapy (SAbR) for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-cell (CAR-T) Salvage Therapy.

If you’re interested in a clinical trial, please talk to your doctor.

Learn more about clinical trials.

Helpful Resources